"Dr. Tracy Beth Hoeg will be replaced as FDA's acting drug center director by Dr. Mike Davis, who has been serving as deputy director, according to an email sent to agency staff Friday that was obtained by The Associated Press."
"Hoeg said in a social media post late Friday that she was "fired," from the agency, adding: "I learned so much and leave with no regrets.""
"The agency also announced Friday that Karim Mikhail would take over as acting director of the vaccines center. Mikhail, a longtime pharmaceutical executive, was hired by Makary last spring."
"Hoeg's rapid rise through the agency was engineered by Makary, who quickly promoted her from serving as his special assistant to overseeing the agency's largest center, responsible for regulating most U.S. prescription and over-the-counter drugs. FDA center directors are typically career agency scientists with decades of experience. Hoeg had no previous government or management experience."
Mike Davis will become acting director of the FDA’s drug center, replacing Tracy Beth Hoeg, who had served as acting director. Hoeg said she was fired in a late Friday social media post and left without regrets. The change follows broader leadership turmoil at the FDA, including the resignation of Commissioner Marty Makary and the stepping down of Vinay Prasad, the vaccine and biotech chief. The FDA also named Karim Mikhail as acting director of the vaccines center. Hoeg had been promoted rapidly by Makary despite lacking prior government or management experience. Her tenure included investigations into injectable RSV drugs for children, antidepressants, and COVID-19 vaccinations.
Read at Fortune
Unable to calculate read time
Collection
[
|
...
]